The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy
Open accessAbstract
Two hematopoietic colony-stimulating factors, granulocyte colony- stimulating factor (G-CSF) and granulocyte-macrophage CSF (GM-CSF), have been shown to accelerate leukocyte and neutrophil recovery after high-dose chemotherapy and autologous bone marrow (BM) support. Despite their use, a prolonged period of absolute leukopenia persists during which infections and other complications of transplantation occur. We collected large numbers of peripheral blood (PB) progenitors after CSF administration using either G-CSF or GM-CSF and tested their ability to affect hematopoietic reconstitution and resource utilization in patients undergoing high-dose chemotherapy and autologous BM support. Patients with breast cancer or melanoma undergoing high-dose chemotherapy and autologous BM support were studied in sequential nonrandomized trials. After identical high-dose chemotherapy, patients received either BM alone, with no CSF; BM with either G-CSF or GM-CSF; or BM with G-CSF or GM-CSF and G-CSF or GM-CSF primed peripheral blood progenitor cells (PBPC). Hematopoietic reconstitution, as well as resource utilization, was monitored in these patients. The use of CSF- primed PBPC led to a highly significant reduction in the duration of leukopenia with a white blood cell (WBC) count under 100 and 200 cells/mL, and neutrophil count under 100 and 200 cells/mL with both GM- and G-CSF primed PB progenitor cells, compared with the use of the CSF with BM or with historical controls using BM alone. In addition, the use of CSF-primed PBPC resulted in a significant reduction in median number of antibiotics used, days in the Bone Marrow Transplant Unit, and hospital resources used. Patients receiving G-CSF primed PBPC also experienced a reduction in the median number of days in the hospital, red blood cell (RBC) transfusions, platelet transfusions, days on antibiotics, and discounted hospital charges. Phenotypic analysis of the CSF-primed PBPC indicated the presence of cells bearing antigens associated with both early and late hematopoietic progenitor cells. The use of CSF-primed PBPC can significantly improve hematopoietic recovery after high-dose chemotherapy and autologous BM support. In addition, the use of G-CSF-primed PBPC was associated with a significant reduction in hospital resource utilization, and a reduction in hospital charges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Simultaneous Statistical Inference
Miller, R. G. (1981) · Springer Series in Statistics · doi:10.1007/978-1-4613-8122-8 · Cited by 5,604
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,575
Sheridan, W. P., Fox, R. M., Begley, C. G., Maher, D., McGrath, K. M., Begley, C. G., Juttner, C. A., To, L. B., Szer, J., & Mostyn, G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90795-5 · Cited by 857
Brandt, S. J., Peters, W. P., Atwater, S. K., Kurtzberg, J., Borowitz, M. J., Jones, R. B., Shpall, E. J., Bast, R. C., Gilbert, C. J., & Oette, D. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804073181401 · Cited by 754
Self-citationGianni, A., Bregni, M., Stern, A., Siena, S., Tarella, C., Pileri, A., & Bonadonna, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90711-3 · Cited by 740
Socinski, M., Elias, A., Schnipper, L., Cannistra, S., Antman, K., & Griffin, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92012-0 · Cited by 562
Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonadonna, G., & Gianni, A. (1989) · Blood · doi:10.1182/blood.v74.6.1905.1905 · Cited by 534
Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Ac, S., Lansdorp, P., Bonadonna, G., & Gianni, A. (1991) · Blood · doi:10.1182/blood.v77.2.400.400 · Cited by 508
Nemunaitis, J., Rabinowe, S. N., Singer, J. W., Bierman, P. J., Vose, J. M., Freedman, A. S., Onetto, N., Gillis, S., Oette, D., Gold, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106203242504 · Cited by 486
Sheridan, W. P., Wolf, M., Lusk, J., Layton, J. E., Souza, L., Morstyn, G., Dodds, A., Maher, D., Green, M. D., & Fox, R. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91552-3 · Cited by 419
Cited by
Aiuti, A., Webb, I. J., Bleul, C., Springer, T., & Gutierrez-Ramos, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.111 · Cited by 1,158
The Biology and Clinical Uses of Blood Stem Cells
To, L. B., Haylock, D. N., Simmons, P. J., & Juttner, C. A. (1997) · Blood · doi:10.1182/blood.v89.7.2233 · Cited by 689
Filgrastim (r-metHuG-CSF): the first 10 years
Welte, K., Gabrilove, J., Bronchud, M., Platzer, E., & Morstyn, G. (1996) · Blood · doi:10.1182/blood.v88.6.1907.bloodjournal8861907 · Cited by 599
Therapeutic Relevance of CD34 Cell Dose in Blood Cell Transplantation for Cancer Therapy
Siena, S., Schiavo, R., Pedrazzoli, P., & Carlo-Stella, C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1360 · Cited by 312
Lane, T., Law, P., Maruyama, M., Young, D., Burgess, J., Mullen, M., Mealiffe, M., Terstappen, L., Hardwick, A., & Moubayed, M. (1995) · Blood · doi:10.1182/blood.v85.1.275.bloodjournal851275 · Cited by 293
Metadata
- Authors
- Peters, W., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C., & Kurtzberg, J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1993-04-01
- Volume
- 81
- Issue
- 7
- Pages
- 1709-1719
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1554216517
- Cited by
- 285
- References
- 16
- FWCI
- 26.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. https://app.cochat.ai/papers/10.1182/blood.v81.7.1709.1709
- The paper
- Peters, W., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C., & Kurtzberg, J. (1993). Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood. https://doi.org/10.1182/blood.v81.7.1709.1709
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.